Anti-Human CD80 (B7-1) Functional Grade Purified

Also known as: B7, BB1

Clone: 2D10.4

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 16-0809

Cat. No. Size
16-0809-81 50 ug
16-0809-85 500 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD80 (B7-1) Functional Grade Purified.

Description

Description: The 2D10.4 monoclonal antibody reacts with human CD80 (B7-1), a 60 kDa member of the Ig superfamily. CD80 is expressed by activated B cells, macrophages and dendritic cells. In addition, activated T cells express this antigen. CD80 has high affinity for binding to two T cell surface antigens, CD28 and CD152 (CTLA-4). The interaction of CD28 and CD152 with CD80 is crucial in T-B cell communication leading to activation of T and B cells, respectively.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate Functional Grade Purified
Reported Applications Flow Cytometric Analysis, Functional Assays
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-0809 Anti-Human CD80 (B7-1) Biotin FC RUO
46-0809 Anti-Human CD80 (B7-1) PerCP-eFluor® 710 488 nm 710 nm FC RUO
11-0809 Anti-Human CD80 (B7-1) FITC 488 nm 518 nm FC RUO
14-0809 Anti-Human CD80 (B7-1) Purified FC RUO
15-0809 Anti-Human CD80 (B7-1) PE-Cy5 488 - 561 nm 670 nm FC RUO
12-0809 Anti-Human CD80 (B7-1) PE 488 - 561 nm 575 nm FC RUO
References

References:
Bashuda, H., Kimikawa, M., Seino, K., Kato, Y., Ono, F., Shimizu, A., Yagita, H., Teraoka, S., and K. Okumura. 2005. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest.115:1896-1902. (2D10.4, FA, PubMed)

Kishimoto, T., A.E.G., von dem Borne, et al. eds. 1998 .Leucocyte Typing VI: White Cell Differentiation Antigens. Garland Publishing Inc. London.